Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT00962676
NCT00962676CompletedNot Applicable

Diagnostic Usefulness of Interferon Gamma Release Assay for Active Tuberculosis in Immunocompromised Patients

Yonsei University1 site in 1 country140 target enrollmentStarted: July 2009Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
140
Locations
1
Study OverviewEligibility CriteriaInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

For diagnosis of active tuberculosis, interferon-γ release assay based mycobacterium tuberculosis specific antigen may show higher sensitivity than tuberculin skin test in immunocompromised patients. Therefore, interferon-γ release assay have a role as a rapid diagnostic adjunctive methods for active tuberculosis in immunocompromised patients.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
20 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Patient suspicious of active tuberculosis with immunocompromised condition
  • •Immunocompromised condition patients with
  • •solid cancer with chemotherapy
  • •hematologic malignancy
  • •organ transplantation
  • •immunosuppressant
  • •ESRD on renal replacement therapy
  • •advanced liver cirrhosis

Exclusion Criteria

  • •Patients with
  • •less than 20 years
  • •who don't agree the participation of study
  • •hypersensitivity history to tuberculin

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Interferon-Gamma Release Assays in Tuberculosis (TB) - HIV Co-infected ChildrenHIVTuberculosis
NCT00604617Case Western Reserve University564
Completed
Not Applicable
Diagnosis of Tuberculosis Infection in Health Care Workers Using Ex-vivo Interferon-gamma AssayLatent Tuberculosis Infection
NCT01007396Samsung Medical Center322
Completed
Not Applicable
Prognostic Value of Interferon Gamma Release Assays in Predicting Active Tuberculosis Among Individuals With, or at Risk of, Latent Tuberculosis InfectionLatent TuberculosisTuberculosis
NCT01162265Public Health England10,000
Completed
Not Applicable
Monthly Follow up of Interferon Gamma Releasing Assay (IGRA) Among Health-care Workers Treating Tuberculosis (TB) PatientsTuberculosis
NCT01121068Seoul National University Hospital49
Completed
Not Applicable
Interferon Gamma Release Assays (IGRA) Testing Versus Tuberculin Skin Test in Renal Transplant RecipientsLatent Tuberculosis Infection
NCT01608685Ligue Pulmonaire Genevoise205
Diagnostic Usefulness of Interferon Gamma... | Clinical Trial